Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8780809 | Gynecologic Oncology | 2017 | 6 Pages |
Abstract
GR expression in primary endometrial cancer is associated with aggressive disease and poor survival. The majority of metastatic endometrial cancer lesions express GR; therefore GR may represent a therapeutic target in the adjuvant therapy of poor prognosis early-stage as well as metastatic endometrial cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ingvild L. Tangen, Jennifer Taylor Veneris, Mari K. Halle, Henrica M. Werner, Jone Trovik, Lars A. Akslen, Helga B. Salvesen, Suzanne D. Conzen, Gini F. Fleming, Camilla Krakstad,